Key result
VT ablation in nonischemic cardiomyopathy patients with isolated potentials resulted in 67% remaining arrhythmia-free, compared to 7% in those without isolated potentials.
Why the study?
Does the presence of isolated potentials (IPs) in conjunction with pace-mapping improve ablation outcomes and arrhythmia-free survival in patients with ventricular tachycardia and nonischemic cardiomyopathy?
Observational (n=35)
Does the presence of isolated potentials (IPs) in conjunction with pace-mapping improve ablation outcomes and arrhythmia-free survival in patients with ventricular tachycardia and nonischemic cardiomyopathy?
The presence of isolated potentials during sinus rhythm identifies critical isthmus areas for VT ablation in nonischemic cardiomyopathy and is associated with significantly higher arrhythmia-free survival.
Answers are grounded in this paper and cite their sources.
May guide ablation targets in nonischemic cardiomyopathy VT; leaves open need for randomized confirmation.
BACKGROUND: In patients with prior infarction, isolated potentials (IPs) during sinus rhythm reflect fixed scar and often indicate sites critical for ventricular tachycardia (VT). The purpose of this study was to determine the value of IPs in conjunction with pace-mapping to guide VT ablation in patients with various types of nonischemic cardiomyopathy. METHODS: Mapping and ablation of VT were performed in 35 consecutive patients (26 men, age 55 ± 13 years, ejection fraction 0.31 ± 0.14) with VT and various etiologies of nonischemic cardiomyopathy. Pace-mapping was performed at sites with low voltage. Radiofrequency energy was delivered at sites with concealed entrainment or matching pace-maps. RESULTS: One hundred ninety-five VTs (mean cycle length 363 ± 88 ms) were induced. Sites with prespecified ablation criteria displaying IPs during sinus rhythm were recorded in 21 of 35 patients (60%, IP-positive). In these patients, a total of 216 sites meeting prespecified ablation criteria were identified and 146 of 216 sites (68%) displayed IPs. Fifteen of 21 IP-positive patients (71%) no longer had inducible VT after ablation. In 14 of 35 patients, no sites with IPs where prespecified ablation criteria were met were identified (IP-negative) despite combined endocardial and epicardial mapping in 7 of 14 patients. Only 1 of 14 IP-negative patients (7%) no longer had inducible VT at the end of the ablation procedure. During a mean follow-up of 18 ± 13 months, 14 of 21 IP-positive patients (67%) remained arrhythmia-free, compared to 1 of 14 IP-negative patients (7%; P < 0.01). Half of the IP-negative patients had major adverse events due to recurrent arrhythmias, compared to none in IP-positive patients. CONCLUSION: IPs in conjunction with pace-mapping are helpful for identifying critical isthmus areas for ablation of VT in patients with various types of nonischemic cardiomyopathy. Patients with nonischemic cardiomyopathy in whom the arrhythmogenic substrate is characterized by IPs have a more favorable outcome than patients in whom IPs are absent.
No takes yet. Share an insight, caveat, or question.
Kühne et al. (2010) conducted an observational in Ventricular tachycardia in nonischemic cardiomyopathy (n=35). Ablation guided by isolated potentials (IPs) and pace-mapping vs. Absence of isolated potentials (IP-negative) was evaluated on Remaining arrhythmia-free during follow-up (p=< 0.01). VT ablation in nonischemic cardiomyopathy patients with isolated potentials resulted in 67% remaining arrhythmia-free, compared to 7% in those without isolated potentials.
Synapse has enriched 10 related papers. Consider them for comparative context: